Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001493152-24-035018
Filing Date
2024-09-04
Accepted
2024-09-04 18:43:27
Documents
21

Document Format Files

Seq Description Document Type Size
1 forms-1.htm   iXBRL S-1 484175
2 ex5-1.htm EX-5.1 18239
3 ex23-2.htm EX-23.2 3766
4 ex107.htm EX-FILING FEES 20284
5 forms-1_001.jpg GRAPHIC 5340
6 ex5-1_003.jpg GRAPHIC 2991
7 ex5-1_004.jpg GRAPHIC 13128
8 ex5-1_005.jpg GRAPHIC 5613
  Complete submission text file 0001493152-24-035018.txt   865775

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE envb-20240830.xsd EX-101.SCH 3257
10 XBRL DEFINITION FILE envb-20240830_def.xml EX-101.DEF 30345
11 XBRL LABEL FILE envb-20240830_lab.xml EX-101.LAB 37018
12 XBRL PRESENTATION FILE envb-20240830_pre.xml EX-101.PRE 27396
23 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 4848
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-281934 | Film No.: 241278856
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)